Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-196,400
Closed -$2.7M 6401
2025
Q1
$2.7M Buy
+196,400
New +$2.7M ﹤0.01% 3488
2024
Q4
Sell
-20,500
Closed -$368K 6535
2024
Q3
$368K Hold
20,500
﹤0.01% 5062
2024
Q2
$361K Hold
20,500
﹤0.01% 4801
2024
Q1
$526K Hold
20,500
﹤0.01% 4774
2023
Q4
$534K Buy
+20,500
New +$468K ﹤0.01% 4601
2023
Q3
Sell
-85,000
Closed -$1.99M 6642
2023
Q2
$1.99M Buy
+85,000
New +$1.44M ﹤0.01% 3485
2022
Q2
Sell
-29,300
Closed -$882K 7584
2022
Q1
$882K Buy
+29,300
New +$914K ﹤0.01% 4655

Other funds holding XP

Israel Englander's XP Position: Q2 2026 in Review

Israel Englander increased its XP (XP) stake by 365% in Q2 2026, buying an estimated $3.09M and bringing the position to 221,187 shares worth $3.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3310.

Israel Englander first reported a position in XP in Q4 2019 and has held it in 27 quarters since. The position peaked at $111M in Q2 2024. 319 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • Israel Englander held 221,187 shares of XP worth $3.6M as of Q2 2026.
  • Israel Englander bought 173,595 XP shares in Q2 2026, an estimated $3.09M.
  • XP made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3310 holding.
  • Israel Englander first reported a position in XP in Q4 2019 and has held it in 27 quarters since.
  • Israel Englander's XP position peaked at $111M in Q2 2024.
  • 319 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.